09:15 HUA HAN BIO-PHARMACEUTICAL HOLDINGS LIMITED<00587> - Ann (1) This announcement is for information purposes only and does not constitute an invitation or offer to acquire, purchase or subscribe for securities. The Stock Exchange of Hong Kong Limited (the `Stock Exchange') and Hong Kong Securities Clearing Company Limited (`HKSCC') take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. Unless otherwise defined, terms used herein shall have the same meanings as those defined in the prospectus of Hua Han Bio-Pharmaceutical Holdings Limited (the `Company') dated 28th November, 2002 (the `Prospectus'). Hua Han Bio-Pharmaceutical Holdings Limited (incorporated in the Cayman Islands with limited liability) NEW ISSUE AND OFFER FOR SALE BY WAY OF PLACING AND PUBLIC OFFER Number of Offer : 142,000,000 Shares Shares comprising 99,400,000 New Shares and 42,600,000 Sale Shares (subject to Over-allotment Option) Number of Placing : 127,800,000 Shares Shares comprising 85,200,000 New Shares and 42,600,000 Sale Shares (subject to reallocation and Over-allotment Option) Number of Public : 14,200,000 New Offer Shares Shares (subject to reallocation) Offer Price : not more than HK$0.87 per Offer Share (payable in full on application and subject to refund) and expected to be not less than HK$0.74 per Offer Share Nominal Value : HK$0.10 each Stock Code : 587 Sponsor Co-sponsor Deloitte & Touche Guotai Junan Corporate Finance Ltd Capital Limited Lead Manager Guotai Junan Securities (Hong Kong) Limited Co-Lead Managers CITIC Capital Markets CM-CCS Securities Limited Limited Co-Managers First Shanghai Securities Tai Fook Securities Company Limited Limited Barits Securities (Hong Kong) Kingsway SW Securities Limited Limited OpenOffering Capital Limited Application has been made to the Listing Committee of the Stock Exchange for the listing of, and permission to deal in, the shares of HK$0.10 each (the `Shares') in the share capital of the Company in issue and to be issued as described in the Prospectus and the relevant application forms relating thereto, including any Shares which may fall to be issued upon the exercise of the Over-allotment Option and the PI Options (as defined in the Prospectus). Dealings in the Shares on the Stock Exchange are expected to commence on Tuesday, 10th December, 2002. Subject to the granting of the listing of, and